Company Beijing Hotgen Biotech Co., Ltd.
Equities
688068
CNE100003P82
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
30.93 CNY | +4.18% | +7.73% | -24.65% |
Apr. 29 | Beijing Hotgen Biotech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 16 | Beijing Hotgen Biotech to Buy Kaijing Gene Technology for 11 Million Yuan | MT |
Business Summary
Number of employees: 1,036
Sales per Business
CNY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Reagents
94.1
%
| 3,517 | 98.9 % | 509 | 94.1 % | -85.52% |
Instruments
3.8
%
| 12 | 0.3 % | 21 | 3.8 % | +77.16% |
Biological Raw Materials
1.5
%
| 4 | 0.1 % | 8 | 1.5 % | +111.13% |
Others
0.6
%
| 24 | 0.7 % | 3 | 0.6 % | -86.26% |
Sales per region
CNY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
China
92.8
%
| 1,335 | 37.8 % | 501 | 92.8 % | -62.44% |
Overseas
7.2
%
| 2,197 | 62.2 % | 39 | 7.2 % | -98.23% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chang Qing Lin
CEO | Chief Executive Officer | 48 | 05-06-22 |
Jing Li
CHM | Chairman | 46 | 06-11-30 |
Yong Zhan Shi
DFI | Director of Finance/CFO | 42 | 15-01-31 |
Yong Qiao
CTO | Chief Tech/Sci/R&D Officer | 41 | 13-06-30 |
Qi Gao
CTO | Chief Tech/Sci/R&D Officer | 45 | 13-09-30 |
Yan Zhao Li
BRD | Director/Board Member | 41 | 23-09-30 |
Xiao Li Liu
BRD | Director/Board Member | 47 | 12-12-31 |
Shao Hua Yu
BRD | Director/Board Member | 45 | 05-06-30 |
Wei Min
PRN | Corporate Officer/Principal | 40 | 10-04-30 |
Hong Rui Zhang
PRN | Corporate Officer/Principal | 38 | 12-06-30 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Chang Qing Lin
CEO | Chief Executive Officer | 48 | 05-06-22 |
Xin Zhou
BRD | Director/Board Member | 62 | 15-08-31 |
Shao Hua Yu
BRD | Director/Board Member | 45 | 05-06-30 |
Yong Zhan Shi
DFI | Director of Finance/CFO | 42 | 15-01-31 |
Qing Feng Wang
BRD | Director/Board Member | 50 | 16-06-30 |
Shu Kui Dong
BRD | Director/Board Member | 71 | 16-06-30 |
Shen Qi
BRD | Director/Board Member | 53 | 18-05-31 |
Jing Li
CHM | Chairman | 46 | 06-11-30 |
Qi Gao
CTO | Chief Tech/Sci/R&D Officer | 45 | 13-09-30 |
Jianguo Chen
BRD | Director/Board Member | - | 23-09-07 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 95,336,169 | 56,552,569 ( 59.32 %) | 2,861,477 ( 3.001 %) | 59.32 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
2,643,924 | 2.87% | 10,898,440 $ |
Company contact information
Beijing Hotgen Biotech Co., Ltd.
Bldg 10, Hi-end Med Device Indl Park Zhongguancun
102600, Beijing
+
http://www.hotgen.com.cnSector
Sales per Business
Sales per region
1st Jan change | Capi. | |
---|---|---|
-24.65% | 371M | |
-7.16% | 178B | |
-1.23% | 107B | |
-4.86% | 67.04B | |
-4.28% | 47.23B | |
+10.32% | 44.62B | |
+8.14% | 42.5B | |
+15.76% | 29.99B | |
+15.53% | 25.22B | |
-5.88% | 24.14B |
- Stock Market
- Equities
- 688068 Stock
- Company Beijing Hotgen Biotech Co., Ltd.